Va Petrenko1. 1. Auburn University, Department of Pathobiology, AL 36849, USA. petreva@auburn.edu
Abstract
BACKGROUND: New phage-derived biorecognition nanomaterials have emerged recently as a result of the in-depth study of the genetics and structure of filamentous phage and the evolution of phage display technology. OBJECTIVE: This review focuses on the progress made in the development of these new nanomaterials and discusses the prospects of using phage as a bioselectable molecular recognition interface in medical and technical devices. METHODS: The author used data obtained both in his research group and sourced using Science Citation Index (Web of Science) search resources. RESULTS/ CONCLUSION: The merging of phage display technologies with nanotechnology over the past few years has proved promising and has already shown its vitality and productivity by contributing vigorously to different areas of medicine and technology, such as medical diagnostics and monitoring, molecular imaging, targeted drug and gene delivery, vaccine development, as well as bone and tissue repair.
BACKGROUND: New phage-derived biorecognition nanomaterials have emerged recently as a result of the in-depth study of the genetics and structure of filamentous phage and the evolution of phage display technology. OBJECTIVE: This review focuses on the progress made in the development of these new nanomaterials and discusses the prospects of using phage as a bioselectable molecular recognition interface in medical and technical devices. METHODS: The author used data obtained both in his research group and sourced using Science Citation Index (Web of Science) search resources. RESULTS/ CONCLUSION: The merging of phage display technologies with nanotechnology over the past few years has proved promising and has already shown its vitality and productivity by contributing vigorously to different areas of medicine and technology, such as medical diagnostics and monitoring, molecular imaging, targeted drug and gene delivery, vaccine development, as well as bone and tissue repair.
Authors: Gopal Abbineni; Sita Modali; Barbara Safiejko-Mroczka; Valery A Petrenko; Chuanbin Mao Journal: Mol Pharm Date: 2010-08-25 Impact factor: 4.939
Authors: G A Kuzmicheva; P K Jayanna; A M Eroshkin; M A Grishina; E S Pereyaslavskaya; V A Potemkin; V A Petrenko Journal: Protein Eng Des Sel Date: 2009-07-25 Impact factor: 1.650